Unknown

Dataset Information

0

Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection.


ABSTRACT: AIM:No randomized study has been conducted to investigate the use of intravenous paracetamol (acetaminophen, APAP) for the management of fever due to infection. The present study evaluated a new ready-made infusion of paracetamol. METHODS:Eighty patients with a body temperature onset ?38.5°C in the previous 24 h due to infection were randomized to a single administration of placebo (n = 39) or 1 g paracetamol (n = 41), and their temperature was recorded at standard intervals. Rescue medication with 1 g paracetamol was allowed. Serum samples were collected for the measurement of APAP and its metabolites. The primary endpoint was defervescence, defined as a core temperature ?37.1°C. RESULTS:During the first 6 h, defervescence was achieved in 15 (38.5%) patients treated with placebo compared with 33 (80.5%) patients treated with paracetamol 1 g (P < 0.0001). The median time to defervescence with paracetamol 1 g was 3 h. Rescue medication was given to 15 (38.5%) and five (12.2%) patients allocated to placebo and paracetamol, respectively (P = 0.007); nine (60.0%) and two (40.0%) of these patients, respectively, experienced defervescence. No further antipyretic medication was needed for patients becoming afebrile with rescue medication. Serum glucuronide-APAP concentrations were significantly greater in the serum of patients who did not experience defervescence with paracetamol. The efficacy of paracetamol was not affected by serum creatinine. No drug-related adverse events were reported. CONCLUSIONS:The 1 g paracetamol formulation has a rapid and sustainable antipyretic effect on fever due to infection. Its efficacy is dependent on hepatic metabolism.

SUBMITTER: Tsaganos T 

PROVIDER: S-EPMC5346867 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection.

Tsaganos Thomas T   Tseti Ioulia K IK   Tziolos Nikolaos N   Soumelas Georgios-Stefanos GS   Koupetori Marina M   Pyrpasopoulou Athina A   Akinosoglou Karolina K   Gogos Charalambos C   Tsokos Nikolaos N   Karagiannis Asterios A   Sympardi Styliani S   Giamarellos-Bourboulis Evangelos J EJ  

British journal of clinical pharmacology 20161207 4


<h4>Aim</h4>No randomized study has been conducted to investigate the use of intravenous paracetamol (acetaminophen, APAP) for the management of fever due to infection. The present study evaluated a new ready-made infusion of paracetamol.<h4>Methods</h4>Eighty patients with a body temperature onset ≥38.5°C in the previous 24 h due to infection were randomized to a single administration of placebo (n = 39) or 1 g paracetamol (n = 41), and their temperature was recorded at standard intervals. Resc  ...[more]

Similar Datasets

| S-EPMC3794888 | biostudies-literature
| S-EPMC6060974 | biostudies-literature
| S-EPMC4738455 | biostudies-literature
| S-EPMC5998570 | biostudies-other
| S-EPMC2409363 | biostudies-literature
| S-EPMC7886841 | biostudies-literature
| S-EPMC4733531 | biostudies-other
| S-EPMC5901786 | biostudies-literature
| S-EPMC4869432 | biostudies-literature
| S-EPMC6524359 | biostudies-literature